Investors paying attention will buy on this news. Alfacell has plenty of cash to get though FDA approval. ONCONASE is clearly effective...I remember when news on the 316th event was expected by the end of September, then the end of last year...patients are obviously living longer than even Alfacell anticipated. If ACEL announces that they're filing the NDA after analyzing the data it means that Sidransky and Co. are convinced FDA approval is forthcoming
Market Data 
Markets 
AI
